Published 2021
| Version v1
Publication
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study
Creators
- Turner, Nicholas C
- Balmaña, Judith
- Poncet, Coralie
- Goulioti, Theodora
- Tryfonidis, Konstantinos
- Honkoop, Aafke H
- Zoppoli, Gabriele
- Razis, Evangelia
- Johannsson, Oskar T
- Colleoni, Marco
- Tutt, Andrew N
- Audeh, William
- Ignatiadis, Michail
- Mailliez, Audrey
- Trédan, Olivier
- Musolino, Antonino
- Vuylsteke, Peter
- Juan-Fita, Maria Jose
- Macpherson, Iain R J
- Kaufman, Bella
- Manso, Luis
- Goldstein, Lori J
- Ellard, Susan L
- Láng, István
- Jen, Kai Yu
- Adam, Virginie
- Litière, Saskia
- Erban, John
- Cameron, David A
Contributors
Others:
- Turner, Nicholas C
- Balmaña, Judith
- Poncet, Coralie
- Goulioti, Theodora
- Tryfonidis, Konstantino
- Honkoop, Aafke H
- Zoppoli, Gabriele
- Razis, Evangelia
- Johannsson, Oskar T
- Colleoni, Marco
- Tutt, Andrew N
- Audeh, William
- Ignatiadis, Michail
- Mailliez, Audrey
- Trédan, Olivier
- Musolino, Antonino
- Vuylsteke, Peter
- Juan-Fita, Maria Jose
- Macpherson, Iain R J
- Kaufman, Bella
- Manso, Lui
- Goldstein, Lori J
- Ellard, Susan L
- Láng, István
- Jen, Kai Yu
- Adam, Virginie
- Litière, Saskia
- Erban, John
- Cameron, David A
Description
To investigate the activity of niraparib in patients with germline-mutated BRCA1/2 (gBRCAm) advanced breast cancer.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/1055650
- URN
- urn:oai:iris.unige.it:11567/1055650
Origin repository
- Origin repository
- UNIGE